The global therapeutic vaccines market size reached US$ 31.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 71.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.5% during 2024-2032. More Info:- https://www.imarcgroup.com/therapeutic-vaccines-market

1. Global Therapeutic
Vaccines Market
Research and Forecast
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Therapeutic Vaccines
Market: Global Industry Trends, Share, Size, Growth, Opportunity and
Forecast 2024-2032," the global therapeutic vaccines market size reached
US$ 31.3 Billion in 2023.
Therapeutic vaccines are immunotherapy designed to treat existing diseases.
They work by stimulating or boosting the immune system of the body to
recognize and fight specific pathogens or abnormal cells, such as cancer cells.
They target diseases that a person already has as compared to preventive
vaccines, which aim to protect individuals from contracting specific infectious
diseases. They target and treat conditions caused by the virus, such as
precancerous lesions.
Request for a PDF sample of this report:
https://www.imarcgroup.com/therapeutic -vaccines-market/requestsample

4. Report Description
Global Therapeutic Vaccines Market Trends:
The surging prevalence of contagious infections, such as human immunodeficiency virus (HIV), human
papillomavirus (HPV), and acquired immune deficiency syndrome (AIDS), represents one of the major factors
catalyzing the demand for therapeutic vaccines around the world. Moreover, the increasing number of airborne
diseases due to the rising air pollution levels is augmenting the growth of the market.
In addition, the growing number of clinical trials by pharmaceutical companies to improve therapeutic vaccines
that offer long-lasting effects on immunization is influencing the market positively. Apart from this, continual
technological advancements in the vaccine production process are strengthening the growth of the market.
Looking forward, the market value is projected to reach US$ 71.4 Billion by 2032, expanding at a CAGR of
9.5% during 2024-2032.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/therapeutic-vaccines-market

5. Report
Segmentation
Breakup by Type:
• Antigen Vaccines
• Dendritic Cell Vaccine
• DNA Vaccine
• Tumor Cell Vaccines
Breakup by Disease Type:
• Autoimmune Disease Vaccines
• Addiction Vaccine
• Neurological Disease Vaccine
• Infectious Disease Vaccine
• Others
Breakup by Technology:
• Autologous Vaccines

6. Report
Segmentation
• Allogeneic Vaccine
Breakup by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Agenus Inc.
• Argos Therapeutics Inc.
• Bavarian Nordic A/S
• Cel-Sci Corporation
• CSL Limited
• Emergent Biosolutions Inc.
• GSK plc
• Merck & Co. Inc.
• Pfizer Inc.
• Sanofi S.A.

8. Key Questions
Answered in
the Report
What was the size of the global therapeutic vaccines market in
2023?
What is the expected growth rate of the global therapeutic
vaccines market during 2024-2032?
What are the key factors driving the global therapeutic
vaccines market?
What has been the impact of COVID-19 on the global
therapeutic vaccines market?
What is the breakup of the global therapeutic vaccines market
based on the type?
What is the breakup of the global therapeutic vaccines market
based on the disease type?
What is the breakup of the global therapeutic vaccines market
based on the technology?
What are the key regions in the global therapeutic vaccines
market?
Who are the key players/companies in the global therapeutic
vaccines market?

9. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Therapeutic Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Antigen Vaccines
6.1.1 Mark et Trends
6.1.2 Mark et Forecast
6.2 Dendritic Cell Vaccine
6.2.1 Mark et Trends
6.2.2 Mark et Forecast
6.3 DNA Vaccine
6.3.1 Mark et Trends
6.3.2 Mark et Forecast

10. Table of
Contents
6.4 Tumor Cell Vaccines
6.4.1 Mark et Trends
6.4.2 Mark et Forecast
7 Market Breakup by Disease Type
7.1 Autoimmune Disease Vaccines
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 Addiction Vaccine
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
7.3 Neurological Disease Vaccine
7.3.1 Mark et Trends
7.3.2 Market Forecast
7.4 Infectious Disease Vaccine
7.4.1 Mark et Trends
7.4.2 Mark et Forecast
7.5 Others
7.5.1 Mark et Trends
7.5.2 Mark et Forecast
8 Market Breakup by Technology
8.1 Autologous Vaccines
8.1.1 Mark et Trends
8.1.2 Mark et Forecast
8.2 Allogeneic Vaccine
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/therapeutic -vaccines-market/toc

11. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

12. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com